Suppr超能文献

波兰葡萄膜黑色素瘤患者队列中的其他原发性恶性肿瘤:644 例长期随访患者的回顾性研究。

Additional primary malignancies in a Polish cohort of uveal melanoma patients: a review of 644 patients with long-term follow-up.

机构信息

Department of Ophthalmology, Poznań University of Medical Sciences, Poznań, Poland.

Polyclinic of Plastic and Ophthalmic Surgery, Kobylniki, Poland.

出版信息

BMC Ophthalmol. 2023 Dec 12;23(1):506. doi: 10.1186/s12886-023-03246-z.

Abstract

AIM

To investigate the frequency and location of additional primary malignancies in a Polish cohort of uveal melanoma (UM) patients registered in a single centre database.

MATERIAL AND METHOD

Retrospective data analysis of patients treated for uveal melanoma at the Department of Ophthalmology, Poznań University of Medical Sciences, Poland between 1991 and 2017. Data on the diagnosis of the additional malignancies were obtained during the follow-up visits in our Department and/or from the Greater Poland Cancer Registry. The exclusion criteria comprised no confirmed follow-up or incomplete clinical entry data.

RESULTS

Among 644 UM patients registered in the database up to 2017, the additional malignancy was diagnosed in 126 (20%) patients: 71 men, 55 women at the median age of 67 years (range: 34-94). In 48 patients (38%), the additional malignancy occurred prior to the diagnosis of UM, in 73 (58%) patients - after it. The most common locations of second cancer were skin (20 cases / 15%), breast (17 cases / 13%) and lungs (15 cases / 12%). The median follow-up was 36 months (range: 3-242). 87 patients (69%) died by the study close, 32 (37%) of them due to metastatic disease from uveal melanoma, 41 (47%) due to another cancer.

CONCLUSIONS

The frequency of additional primary malignancies was higher in our cohort than reported by most of other groups. If there is a certain predisposition to a specific type of additional primary carcinoma in UM patients, the analysis of larger database is required.

摘要

目的

在波兰一个单中心数据库中登记的葡萄膜黑色素瘤(UM)患者队列中,调查额外原发性恶性肿瘤的发生频率和部位。

材料与方法

对 1991 年至 2017 年期间在波兰波兹南医科大学眼科接受治疗的葡萄膜黑色素瘤患者进行回顾性数据分析。在我们的科室随访期间或从大波兰癌症登记处获得有关额外恶性肿瘤诊断的数据。排除标准包括无确认随访或不完整的临床条目数据。

结果

在截至 2017 年登记在数据库中的 644 名 UM 患者中,有 126 名(20%)患者被诊断出患有其他恶性肿瘤:男性 71 名,女性 55 名,中位年龄为 67 岁(范围:34-94)。在 48 名患者(38%)中,额外恶性肿瘤发生在 UM 诊断之前,在 73 名患者(58%)中发生在 UM 诊断之后。第二癌症最常见的部位是皮肤(20 例/15%)、乳房(17 例/13%)和肺部(15 例/12%)。中位随访时间为 36 个月(范围:3-242)。在研究结束时,有 87 名患者(69%)死亡,其中 32 名(37%)死于转移性 UM 疾病,41 名(47%)死于另一种癌症。

结论

在我们的队列中,额外原发性恶性肿瘤的发生率高于大多数其他研究报道。如果 UM 患者存在某种特定类型的额外原发性癌的易感性,则需要对更大的数据库进行分析。

相似文献

2
Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Br J Ophthalmol. 2016 Mar;100(3):356-9. doi: 10.1136/bjophthalmol-2015-306914. Epub 2015 Jul 15.
3
Characterizations of uveal melanoma patients with three additional primary malignancies.
Acta Ophthalmol. 2024 Sep;102(6):690-696. doi: 10.1111/aos.16631. Epub 2024 Jan 16.
4
Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohort.
Acta Ophthalmol. 2023 Sep;101(6):696-704. doi: 10.1111/aos.15659. Epub 2023 Mar 16.
5
Uveal melanoma-associated cancers revisited.
ESMO Open. 2020 Nov;5(6):e000990. doi: 10.1136/esmoopen-2020-000990.
6
Uveal metastasis revealing lung cancer.
J Fr Ophtalmol. 2012 Jun;35(6):420-5. doi: 10.1016/j.jfo.2011.12.005. Epub 2012 May 23.
7
Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
Singapore Med J. 2019 Sep;60(9):474-478. doi: 10.11622/smedj.2019054. Epub 2019 Jun 14.
9
Multiple neoplasms in patients with uveal melanoma: a systematic review.
Int Ophthalmol. 2024 Jun 22;44(1):256. doi: 10.1007/s10792-024-03164-z.
10
The genetic basis of uveal melanoma.
J Fr Ophtalmol. 2015 Jun;38(6):516-21. doi: 10.1016/j.jfo.2015.04.003. Epub 2015 May 11.

本文引用的文献

1
Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohort.
Acta Ophthalmol. 2023 Sep;101(6):696-704. doi: 10.1111/aos.15659. Epub 2023 Mar 16.
2
Cancer incidence and mortality in Poland in 2019.
Sci Rep. 2022 Jun 27;12(1):10875. doi: 10.1038/s41598-022-14779-6.
3
Contemporary trends in management of uveal melanoma.
J Contemp Brachytherapy. 2022 Apr;14(2):123-129. doi: 10.5114/jcb.2022.115210. Epub 2022 Apr 2.
4
Germline MBD4 deficiency causes a multi-tumor predisposition syndrome.
Am J Hum Genet. 2022 May 5;109(5):953-960. doi: 10.1016/j.ajhg.2022.03.018. Epub 2022 Apr 22.
6
Risk of New Primary Cancer in Patients with Posterior Uveal Melanoma: A National Cohort Study.
Cancers (Basel). 2022 Jan 7;14(2):284. doi: 10.3390/cancers14020284.
7
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.
Cancers (Basel). 2021 Dec 25;14(1):96. doi: 10.3390/cancers14010096.
8
Uveal Melanoma Metastasis.
Cancers (Basel). 2021 Nov 13;13(22):5684. doi: 10.3390/cancers13225684.
9
Uveal melanoma diagnosis and current treatment options (Review).
Exp Ther Med. 2021 Dec;22(6):1428. doi: 10.3892/etm.2021.10863. Epub 2021 Oct 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验